Yubo International Biotech Ltd (YBGJ) Stock Forecast Nov. 4, 2026
Analysis updated on Nov. 4, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Yubo International Biotech Ltd (YBGJ) stock forecast summary
This forecast was produced 3 trading days ago and has not been refreshed since; read it as historical, not as a current view.
Its market capitalization is not available, so no size classification is given.
For YBGJ, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -30.0%, measured on 358 forecast dates between 2022-08-17 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-17 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)
YBGJ price chart and AI forecast
How YBGJ ranks among 5150 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Yubo International Biotech Ltd (YBGJ) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Electromedical & Electrotherapeutic Apparatus peers listed below that report each metric.
Valuation & Market
| Metric | YBGJ | Rank |
|---|---|---|
| EPS | $-0.01 | – |
Profitability & Margins
| Metric | YBGJ | Rank |
|---|---|---|
| Tax Rate | 0.0% | – |
Financial Health
| Metric | YBGJ | Rank |
|---|---|---|
| Current Ratio | 0.18x | 27/28 |
| Quick Ratio | 0.17x | 26/27 |
| Interest Coverage | 7298.4x | 1/28 |
| Working Capital | -$3M | 26/27 |
Cash Flow
| Metric | YBGJ | Rank |
|---|---|---|
| Operating Cash Flow | -$780K | 12/28 |
Operational Efficiency
| Metric | YBGJ | Rank |
|---|---|---|
| Receivables Turnover | 0.1x | 20/20 |
| Inventory Turnover | 0.2x | 26/26 |
| Fixed Assets Turnover | 0.7x | 20/20 |
| Days Sales Outstanding | 4079 days | 1/20 |
| Days Inventory | 2162 days | 1/26 |
| Payables Period | 113947 days | 1/24 |
| Cash Conversion Cycle | -107706 days | 19/19 |
Income Statement
| Metric | YBGJ | Rank |
|---|---|---|
| Total Revenue | $10K | 19/19 |
| Operating Income | -$1M | 10/28 |
| Net Income | -$920K | 10/20 |
| Cost of Goods Sold | $0.00M | 26/26 |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $580K | |
| Cash & Short-term Investments | $10K | |
| Accounts Receivable | $140K | |
| Inventory | $20K | |
| Total Liabilities | $5M | |
| Short-term Debt | $2M |
YBGJ quarterly financials and insider trading
Yubo International Biotech Ltd (YBGJ) industry peers
Companies classified under the same SEC industry code as Yubo International Biotech Ltd (Electromedical & Electrotherapeutic Apparatus): 30 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| YBGJ Yubo International Biotech Ltd | N/A | |
| MDT Medtronic Plc | $134.10B | |
| LIVN Livanova Plc | $4.96B | |
| ITGR Integer Holdings Corp | $4.30B | |
| AXGN Axogen, Inc. | $2.99B | |
| TMDX Transmedics Group, Inc. | $2.39B | |
| CNMD Conmed Corp | $1.53B | |
| CBLL Ceribell, Inc. | $1.02B | |
| INMD Inmode Ltd. | $766M | |
| CV Capsovision, Inc | $310M | |
| ELMD Electromed, Inc. | $227M | |
| FOCL Edap Tms Sa | $125M | |
| STXS Stereotaxis, Inc. | $109M | |
| VANI Vivani Medical, Inc. | $94M | |
| OM Outset Medical, Inc. | $77M | |
| NRXS Neuraxis, Inc | $77M | |
| HYPR Hyperfine, Inc. | $73M | |
| ECOR Electrocore, Inc. | $65M | |
| POCI Precision Optics Corporation, Inc. | $54M | |
| POSC Positron Corp | $54M | |
| VASO Vaso Corp | $51M | |
| QTI Qt Imaging Holdings, Inc. | $30M | |
| ITOC Itonic Holdings Ltd | $12M | |
| IRIX Iridex Corp | $12M | |
| GTHP Guided Therapeutics Inc | $10M | |
| NDRA Endra Life Sciences Inc. | $8M | |
| ADMT Adm Tronics Unlimited, Inc. | $6M | |
| NUWE Nuwellis, Inc. | $2M | |
| ESMC Escalon Medical Corp | $1M | |
| NXL Nexalin Technology, Inc. | $1M |
Where YBGJ sits on the market map
Yubo International Biotech Ltd (YBGJ) stock news
Loading...
Yubo International Biotech Ltd (YBGJ) stock forecast FAQ
What is the Yubo International Biotech Ltd (YBGJ) stock forecast?
This forecast was produced 3 trading days ago and has not been refreshed since; read it as historical, not as a current view.
How accurate are Yubo International Biotech Ltd stock predictions?
For YBGJ, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -30.0%, measured on 358 forecast dates between 2022-08-17 and 2026-08-06 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -18.0%, measured on 400 forecast dates between 2022-08-17 and 2026-10-05. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Yubo International Biotech Ltd forecasts updated?
Yubo International Biotech Ltd forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 4, 2026.
Which companies are Yubo International Biotech Ltd's industry peers?
30 issuers in our coverage, YBGJ included, share the SEC industry code Electromedical & Electrotherapeutic Apparatus. The largest are: Medtronic Plc (MDT), Livanova Plc (LIVN), Integer Holdings Corp (ITGR), Axogen, Inc. (AXGN), Transmedics Group, Inc. (TMDX), Conmed Corp (CNMD).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.